| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Caris Life Sciences, Inc. | Director | Common Stock | 307,594 | $8,154,316 | $26.51 | 11 Aug 2025 | By Family Trust |
| Caris Life Sciences, Inc. | Director | Common Stock | 220,237 | $6,552,050 | $29.75 | 11 Aug 2025 | Direct |
| EXELIXIS, INC. | Director | Common Stock | 178,832 | $6,468,353 | $36.17 | 29 May 2025 | Direct |
| Caris Life Sciences, Inc. | Director | Stock Option | 0 | 11 Aug 2025 | Direct | ||
| EXELIXIS, INC. | Director | Option (right to buy) | 0 | 16 May 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CAI | Caris Life Sciences, Inc. | 11 Aug 2025 | 4 | -$3,845,630 | 4 | Director | 13 Aug 2025, 20:07 |
| CAI | Caris Life Sciences, Inc. | 17 Jun 2025 | 0 | $0 | 3 | Director | 17 Jun 2025, 21:33 |
| EXEL | EXELIXIS, INC. | 29 May 2025 | 1 | $0 | 4 | Director | 30 May 2025, 19:14 |
| EXEL | EXELIXIS, INC. | 16 May 2025 | 3 | -$541,023 | 4 | Director | 16 May 2025, 20:58 |
| EXEL | EXELIXIS, INC. | 14 Feb 2025 | 3 | -$226,045 | 4 | Director | 19 Feb 2025, 20:32 |
| EXEL | EXELIXIS, INC. | 01 Nov 2024 | 1 | -$1,020,000 | 4 | Director | 05 Nov 2024, 19:04 |
| EXEL | EXELIXIS, INC. | 08 Aug 2024 | 1 | -$906,865 | 4 | Director | 12 Aug 2024, 19:22 |
| EXEL | EXELIXIS, INC. | 31 May 2024 | 1 | $0 | 4 | Director | 04 Jun 2024, 20:21 |
| EXEL | EXELIXIS, INC. | 21 May 2024 | 3 | -$16,243 | 4 | Director | 22 May 2024, 19:23 |
| EXEL | EXELIXIS, INC. | 01 Jun 2023 | 1 | $0 | 4 | Director | 02 Jun 2023, 21:20 |
| EXEL | EXELIXIS, INC. | 29 Nov 2022 | 3 | -$415,200 | 4 | Director | 01 Dec 2022, 19:11 |
| EXEL | EXELIXIS, INC. | 26 May 2022 | 1 | $0 | 4 | Director | 27 May 2022, 21:23 |
| EXEL | EXELIXIS, INC. | 27 May 2021 | 1 | $0 | 4 | Director | 28 May 2021, 20:13 |
| EXEL | EXELIXIS, INC. | 14 May 2021 | 1 | -$1,018,825 | 4 | Director | 17 May 2021, 20:11 |